Loading
Thoracic medical oncologist who serves as CEO of the International Association for the Study of Lung Cancer.
Karen Kelly is Chief Executive Officer of the International Association for the Study of Lung Cancer (IASLC). A thoracic medical oncologist, she previously led cooperative-group lung cancer trials in the United States and held academic leadership roles before moving to lead the society. She oversees IASLC's scientific meetings, staging project and global education programmes.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares International Association for the Study of Lung Cancer, Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Mesothelioma, Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Mesothelioma, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Mesothelioma, Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.